Skip to main content

Plaintiffs Seek To Revive Reversed $83M Pelvic Mesh Verdicts

Plaintiffs Seek To Revive Reversed $83M Pelvic Mesh Verdicts

Plaintiffs Seek To Revive Reversed $83M Pelvic Mesh Verdicts

Introduction

Earlier this month, a three-judge appeals panel had reversed two verdicts worth $83 million awarded to two women and their husbands over complications from pelvic mesh medical devices and now the two couples have appealed to the New Jersey Supreme Court to reinstate the same.

Last Friday, the two couples challenged the March 2 opinion of the Superior Court of New Jersey Appellate Division and told the Supreme Court justices that the appellate panel incorrectly tossed the verdict over the exclusion of evidence that the companies' pelvic mesh products were cleared through the U.S. Food and Drug Administration's 510(k) process.

The New Jersey appeals court panel had consolidated both the cases and overturned the verdicts, which were awarded by two separate Bergen County juries to the plaintiffs.

The first case was brought against Johnson & Johnson (J&J), Ethicon Inc., Ethicon Women's Health and Urology, and Gynecare, in which a Bergen County jury had awarded the woman and her husband $5 million in compensatory damages and $10 million in punitive damages. The jury held the defendants liable under independent theories of defective design and inadequate warning under New Jersey product liability laws.

The second case had resulted in $33 million in compensatory damages, along with stipulated medical expenses, and another $35 million in punitive damages. The jury held C.R. Bard, Inc., Bard Medical Division, and Bard Urological Division responsible for design and failure to warn defects claims.

The couples further added that the appellate opinion is internally inconsistent and fails to provide clear guidance to the MCL judge on remand and that both the defendants were not limited in submitting any substantive evidence or argument in their defense, including about their failure to perform clinical studies on the marketed devices.

The couple appealed to the reversal as they felt it was unjust and the opinion would also leave the door open for the MCL Judge to decide that the exclusion of 510(k) evidence remains appropriate on remand, especially outside of punitive damages.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Court Approves $700M Opioid Settlement for Acute Hospitals

Categories: Opioids

A federal court has approved a $700 million class-action settlement that will compensate over 1,000 acute care hospitals for costs related to the opioid crisis.

The settlement consolidates four separate agreements involving major drug…

Philips Settles CPAP Lawsuits Over Toxic Foam for $1.1B

Philips has been embroiled in legal battles following the recall of millions of CPAP, BiPAP, and ventilator devices due to toxic foam degradation.

The breakdown of the foam in these machines may release harmful chemicals, raising serious…

Texas Trial to Decide J&J’s $10B Talcum Powder Settlement

Categories: Talcum

A high-stakes trial in Texas will determine whether Johnson & Johnson (J&J) can resolve tens of thousands of talcum powder cancer lawsuits through a…

🎁 March VIP Medical Record Review Offer – Get 300 Pages Free!         
Includes a Free Life Care Plan Report + 10% Off Future Reviews!

Only 15 Firms Accepted.